THE EFFECTS OF PUTATIVE 5‐HYDROXYTRYPTAMINE ANTAGONISTS ON THE BEHAVIOUR PRODUCED BY ADMINISTRATION OF TRANYLCYPROMINE AND L‐TRYPTOPHAN OR TRANYLCYPROMINE AND L‐DOPA TO RATS

No abstract is available for this paper.

• Publication year

  1978

• Venue

  British Journal of Pharmacology

• Publication date

  1978-10-01

• Fields of study

  Medicine, Chemistry, Psychology

• Identifiers
  DOI 10.1111/j.1476-5381.1978.tb17290.xPMID 708990PMCID PMC1668312
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Evidence for the functional interaction of two central neurotransmitters

  2004cited by this paper
• Postsynaptic serotonin-sensitive adenylate cyclase in the central nervous system. II. Comparison with dopamine- and isoproterenol-sensitive adenylate cyclases in rat brain.

  1978cited by this paper
• Serotonin receptors in the brain.

  1977cited by this paper
• Direct evidence for an interaction of β-adrenergic blockers with the 5-HT receptor

  1977cited by this paper
• Role of tryptaminergic mechanisms in the elements of the behavioural syndrome evoked by tryptophan and a monoamine oxidase inhibitor [proceedings].

  1977cited by this paper
• Blockade of 5-hydroxytryptamine receptors in the central nervous system by beta-adrenoceptor antagonists.

  1977cited by this paper
• Serotonin receptors in the brain.

  1977cited by this paper
• Effects of drugs on the processes regulating the functional activity of brain 5-hydroxytryptamine

  1976cited by this paper
• (−)-Propranolol inhibits the behavioural responses of rats to increased 5-hydroxytryptamine in the central nervous system

  1976cited by this paper
• Behavioral effects of 5, 7-dihydroxytryptamine lesions of ascending 5-hydroxytryptamine pathways.

  1976cited by this paper
• An animal behavior model for studying central serotonergic synapses.

  1976cited by this paper
• Behavioral evidence for supersensitivity following destruction of central serotonergic nerve terminals by 5,7-dihydroxytryptamine.

  1976cited by this paper
• EVIDENCE CONCERNING THE INVOLVEMENT OF 5‐HYDROXYTRYPTAMINE IN THE LOCOMOTOR ACTIVITY PRODUCED BY AMPHETAMINE OR TRANYLCYPROMINE PLUS l‐DOPA

  1976cited by this paper
• Relationship of brain monoamine and locomotor activity in rats.

  1975cited by this paper
• Effects of methergoline on central monoamine neurones. Evidence for a selective blockade of central 5-HT receptors.

  1975cited by this paper
• Brain stem and spinal cord mediation of a serotonergic behavioral syndrome.

  1975cited by this paper
• The role of brain dopamine in the hyperactivity syndrome produced by increased 5-hydroxytryptamine synthesis in rats.

  1974cited by this paper
• Inhibitory effect of chlorpromazine on the syndrome of hyperactivity produced by l‐tryptophan or 5‐methoxy‐N,N‐dimethyltryptamine in rats treated with a monoamine oxidase inhibitor

  1971cited by this paper
• STUDIES IN VIVO ON THE RELATIONSHIP BETWEEN BRAIN TRYPTOPHAN, BRAIN 5‐HT SYNTHESIS AND HYPERACTIVITY IN RATS TREATED WITH A MONOAMINE OXIDASE INHIBITOR AND L‐TRYPTOPHAN

  1971cited by this paper
• Rapid method for the determination of 5‐hydroxytryptamine and 5‐hydroxyindoleacetic acid in small regions of rat brain

  1970cited by this paper
• In vivo measurement of brain serotonin turnover.

  1968cited by this paper
• The effects of 5-hydroxytryptamine antagonists on spinal neuronal activity.

  1968cited by this paper
• Different central mediation of the stimulant effects of amphetamine and its p-chloro analogue.

  1968cited by this paper
• Antagonism of central effects of tryptamine and 5-hydroxytryptophan by 1,6-dimethyl-8β-carbobenzyloxy-aminomethyl-10α-ergoline

  1965cited by this paper
• PHARMACOLOGIC STUDIES OF SOME NONHYDRAZINE MAO INHIBITORS

  1963cited by this paper
• Behavioral effects and brain amine content in rats.

  1961cited by this paper

• The neuroanatomical basis of the 5-HT syndrome and harmaline-induced tremor.

  2023cites this paper
• The Irwin Test and Functional Observational Battery (FOB) for Assessing the Effects of Compounds on Behavior, Physiology, and Safety Pharmacology in Rodents

  2018cites this paper
• The standardized functional observational battery: Its intrinsic value remains in the instrument of measure: The rat.

  2016cites this paper
• The murine serotonin syndrome - evaluation of responses to 5-HT-enhancing drugs in NMRI mice.

  2015cites this paper
• 5-HT1A Receptor Agonist Befiradol Reduces Fentanyl-induced Respiratory Depression, Analgesia, and Sedation in Rats

  2015cites this paper
• Animal models of the serotonin syndrome: a systematic review.

  2013cites this paper
• Regulation of opioid gene expression in the rat brainstem by 3,4-methylenedioxymethamphetamine (MDMA): role of serotonin and involvement of CREB and ERK cascade

  2011cites this paper
• Serotonin syndrome: a case of fatal SSRI/MAOI interaction.

  2009cites this paper
• Differential behavioral syndrome evoked in the rats after multiple doses of SSRI fluoxetine with selective MAO inhibitors rasagiline or selegiline

  2007influential citation
• Monoamine Oxidase Inhibitors and Serotonin Syndrome

  2007cites this paper
• Neuropharmacologic correlates of deglutition: Lessons from fictive swallowing

  2006cites this paper
• 5-Hydroxytryptamine 1A Receptors in the Paraventricular Nucleus of the Hypothalamus Mediate Oxytocin and Adrenocorticotropin Hormone Release and Some Behavioral Components of the Serotonin Syndrome

  2005cites this paper
• An ethopharmacological analysis of the behavioral effects of 8-OH-DPAT

  2005cites this paper
• The Most Common Drug Interactions Associated With the Serotonin Syndrome in 38 Patients in 12 Reports Reference

  2005cites this paper
• Fatigue of cholestasis and the serotoninergic neurotransmitter system in the rat

  2005cites this paper
• The role of 5-HT in the impairment of thermoregulation observed in rats administered MDMA (‘ecstasy’) when housed at high ambient temperature

  2005cites this paper
• The pharmacology of the behavioral and hypothermic responses of rats to 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT)

  2004cites this paper
• Attenuation by electroconvulsive shock and antidepressant drugs of the 5-HT1A receptor-mediated hypothermia and serotonin syndrome produced by 8-OH-DPAT in the rat

  2004cites this paper
• Role of 5-hydroxytryptamine in amphetamine effects on punished and unpunished behaviour

  2004cites this paper
• Proceedings of the British Pharmacological Society

  2004cites this paper
• Effects of Lesopitron on the Central Nervous System Arising from Its Interaction with 5-HT1A Receptors

  2004cites this paper
• Differential effects of 5-hydroxytryptamine antagonists on behaviors resulting from activation of different pathways arising from the raphe nuclei

  2004cites this paper
• Reduced brain serotonergic activity after repeated treatment with β-adrenoceptor antagonists

  2004cites this paper
• Studies on possible mechanisms of action of electroconvulsive therapy; effects of repeated electrically induced seizures on rat brain receptors for monoamines and other neurotransmitters

  2004cites this paper
• The effects of a 5-HT1 receptor ligand isapirone (TVX Q 7821) on 5-HT synthesis and the behavioural effects of 5-HT agonists in mice and rats

  2004cites this paper
• Prevention of the serotonin syndrome in rats by repeated administration of monoamine oxidase inhibitors but not tricyclic antidepressants

  2004cites this paper
• The enhancement by lithium of the 5-HT1A mediated serotonin syndrome produced by 8-OH-DPAT in the rat: evidence for a post-synaptic mechanism

  2004cites this paper
• Effects of genetic background on neonatal Borna disease virus infection-induced neurodevelopmental damage. II. Neurochemical alterations and responses to pharmacological treatments.

  2002cites this paper
• Effects of genetic background on neonatal Borna disease virus infection-induced neurodevelopmental damage. I. Brain pathology and behavioral deficits.

  2002cites this paper
• On the mechanism of tolerance to morphine-induced Straub tail reaction in mice.

  2001cites this paper
• An exploratory approach to the serotonin syndrome: an update of clinical phenomenology and revised diagnostic criteria.

  2000cites this paper
• Serotonin Syndrome Presentation of 2 Cases and Review of the Literature

  2000cites this paper
• Hormones, genes and the structure of sexual arousal.

  1999cites this paper
• Selective serotonin reuptake inhibitors: infrequent medical adverse effects.

  1998influential citation
• Serotonin syndrome.

  1997cites this paper
• Psychotropic and neurotropic activity

  1997cites this paper
• Brain structures involved in the behavioral stimulant effect of central serotonin release.

  1997cites this paper
• Serotonin syndrome.

  1996cites this paper
• Effects of 8‐OHDPAT and 5‐HT1A antagonists WAY100135 and WAY100635, on guinea‐pig behaviour and dorsal raphe 5‐HT neurone firing

  1996cites this paper
• Myo-inositol attenuates the enhancement of the serotonin syndrome by lithium

  1995cites this paper
• Behavioural and neuroendocrine responses to D-fenfluramine in rats treated with neurotoxic amphetamines

  1995cites this paper
• The Serotonin Syndrome

  1995cites this paper
• Interactions between 5-hydroxytryptamine receptor subtypes: is a disturbed receptor balance contributing to the symptomatology of depression in humans?

  1995cites this paper
• Serotonin syndrome: a case of fatal SSRI/MAOI interaction.

  1994cites this paper
• Serotonin Syndrome

  1994cites this paper
• Effects of glucocorticoids on 5-HT1A presynaptic function in the mouse

  1994cites this paper
• Cardiorespiratory arrest following combined spinal epidural anaesthesia

  1994cites this paper
• Treating MDMA (‘Ecstasy’) toxicity

  1994cites this paper
• Differential induction of 5-HT1A-mediated responses in vivo by three chemically dissimilar 5-HT1A agonists.

  1994cites this paper
• Fluoxetine and the serotonin syndrome.

  1994cites this paper
• Tryptamine: A metabolite of tryptophan implicated in various neuropsychiatric disorders

  1993cites this paper
• 5‐HT loss in rat brain following 3, 4‐methylenedioxymethamphetamine (MDMA), p‐chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine

  1993cites this paper
• The effects of adrenalectomy and ovariectomy on the behavioral and hypothermic responses of rats to 8-hydroxy-2(di-n-propylamino)tetralin (8-OH-DPAT).

  1993cites this paper
• Chronic, combined treatment with desipramine and mianserin: enhanced 5-HT1A receptor function and altered 5-HT1A/5-HT2 receptor interaction in rats.

  1993cites this paper
• Antidepressant-like activity of compounds with varying efficacy at 5-HT1A receptors.

  1993cites this paper
• The effects of rubidium, caesium and quinine on 5-HT-mediated behaviour in rat and mouse--1. Rubidium.

  1992cites this paper
• The effects of corticosterone on 5-HT receptor function in rodents.

  1992cites this paper
• Serotonin-dependent cerebral activation: effects of methiothepin and other serotonergic antagonists.

  1992cites this paper
• Astra Award Lecture. The psychopharmacology of 5-HT3 receptors.

  1992cites this paper
• The effect of adrenergic drugs on serotonin metabolism in the nucleus raphe dorsalis of the rat, studied by in vivo voltammetry.

  1992cites this paper
• The effects of rubidium, caesium and quinine on 5-HT-mediated behaviour in rat and mouse--2. Caesium.

  1992cites this paper
• Studies on the enhancement of 5-hydroxytryptamine-mediated behaviour by chlormethiazole and phenytoin

  1992cites this paper
• Desipramine, administered chronically, influences 5-hydroxytryptamine1A-receptors, as measured by behavioral tests and receptor binding in rats.

  1992cites this paper
• The effects of serotonergic stimulation on hippocampal and neocortical slow waves and behavior.

  1991cites this paper
• Involvement of central cholinergic mechanism in RU-24969-induced behavioral deficits.

  1991cites this paper
• Altered behavioral responses mediated by serotonin receptors in the genetically dystonic (dt) rat.

  1991cites this paper
• The serotonin syndrome.

  1991cites this paper
• Destruction of the nucleus raphe obscurus and potentiation of serotonin-mediated behaviors following administration of the neurotoxin 3-acetylpyridine.

  1990cites this paper
• Behavioural evidence for a functional interaction between central 5‐HT2 and 5‐HT1A receptors

  1990cites this paper
• A characterization of the acute cardiopulmonary toxicity of fenfluramine in the rat.

  1990cites this paper
• The effects of Ca2+ antagonists and hydralazine on central 5‐hydroxytryptamine biochemistry and function in rats and mice

  1990cites this paper
• Clomipramine in Obsessive-Compulsive Disorder: Further Evidence for a Serotonergic Mechanism of Action

  1989cites this paper
• Behavioral effects of 8-OH-DPAT: studies using the Microtaxic ventricular injector.

  1989cites this paper
• Bromocriptine-induced hypothermia: D-2 receptor involvement.

  1989cites this paper
• Involvement of 5‐HT2 receptors in the behaviours produced by intrathecal administration of selected 5‐HT agonists and the TRH analogue (CG 3509) to rats

  1989cites this paper
• Long-term imipramine treatment potentiates m-chlorophenylpiperazine-induced changes in prolactin but not corticosterone or growth hormone levels in rats.

  1989cites this paper
• Effect of 1-(m-chlorophenyl)piperazine and 1-(m-trifluoromethylphenyl)piperazine on locomotor activity.

  1989cites this paper
• Clomipramine in obsessive-compulsive disorder. Further evidence for a serotonergic mechanism of action.

  1989cites this paper
• Behavioral Models of Serotonin Receptor Activation

  1988cites this paper
• Selective breeding for increased cholinergic function: increased serotonergic sensitivity.

  1988cites this paper
• Behavioral effects of alpha-benzyl-N-methylphenethylamine (ABNMP), a methamphetamine analog: inhibition by ketanserin and para-chlorophenylalanine (PCPA).

  1988cites this paper
• Cerebrospinal Fluid: Monoamine Metabolites Among Habitually Violent and Impulsive Offenders

  1988cites this paper
• Participation of the serotonin2 receptor in the iminodipropionitrile-induced dyskinetic syndrome.

  1988cites this paper
• Motivational effects of opioids: influence of D-1 versus D-2 receptor antagonists.

  1988cites this paper
• Relationship between extracellular 5‐hydroxytryptamine and behaviour following monoamine oxidase inhibition and l‐tryptophan

  1988cites this paper
• Topical beta-blocker therapy and central nervous system side effects. A preliminary study comparing betaxolol and timolol.

  1988cites this paper
• 5-Hydroxytryptamine antagonists and the 5-methoxy-N,N-dimethyltryptamine-induced changes of postdecapitation convulsions.

  1987cites this paper
• Potentiation in phencyclidine-induced serotonin-mediated behaviors after intracerebroventricular administration of 5,7-dihydroxytryptamine in rats.

  1987cites this paper
• Effects of 5,7-dihydroxytryptamine on serotonin1 and serotonin2 receptors throughout the rat central nervous system using quantitative autoradiography.

  1987cites this paper
• Isolation of post-junctional alpha2-adrenoceptors in the rabbit isolated saphenous vein with phenoxybenzamine

  1987cites this paper
• Serotonin-lesion myoclonic syndromes. II. Analysis of individual syndrome elements, locomotor activity and behavioral correlations.

  1986cites this paper
• Recent advances in central 5-hydroxytryptamine receptor agonists and antagonists.

  1986cites this paper
• [The role of serotonin in the behavioral changes induced in the rat by cyclazocine].

  1986cites this paper
• Blockade of the central 5-HT autoreceptor by β-adrenoceptor antagonists☆

  1986cites this paper
• Reduction of the rewarding effect of brain stimulation by a blockade of dopamine D1 receptor with SCH 23390.

  1986cites this paper
• Blockade of the central 5-HT autoreceptor by beta-adrenoceptor antagonists.

  1986cites this paper
• The effects of monoamine oxidase inhibitors on the ejaculatory response induced by 5‐methoxy‐N,N‐dimethyltryptamine in the rat

  1986cites this paper
• The Pathogenesis of Tourette Syndrome

  1986cites this paper
• 5-Hydroxytryptamine release in vivo from a cytoplasmic pool: studies on the 5-HT behavioural syndrome in reserpinized rats.

  1985cites this paper
• Enhancement of some 5-HT-dependent behavioural responses following repeated immobilization in rats.

  1985cites this paper